Min Kim, PhD, MPH

Amgen, Inc.
Thousand Oaks

I am an epidemiologist by training with prior experience in HIV prevention research and public health. I am currently a director of observational research at Amgen leading real world evidence generation strategy for one of our Bone therapies.

Presentation(s):

• 2528: Current Trends in the Risk of Subsequent Fracture After Initial Fracture, and Post-Fracture Treatment Among Commercially Insured Postmenopausal Women in the United States

  Tuesday, November 14, 2023
  4:15 PM – 4:25 PM PT

  Disclosure information not submitted.